Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Johnson & Johnson Plans JLABS Incubator in Shanghai

publication date: Dec 5, 2017

Johnson & Johnson Innovation plans to open a JLABS life science incubator in Shanghai's Zhangjiang Hi-Tech Park, with space for 50 startup companies. The 47,000 square foot facility, the first JLABS site located outside North America, will be operational in Q2 2019. J&J said JLABS @ Shanghai will seek innovative companies from the entire healthcare spectrum, including pharmaceuticals, medical devices and consumer products. JLABS says its "no strings attached" model offers resident innovators a capital efficient and flexible platform for developing products. More details....

Stock Symbol: (NYSE: JNJ)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.